PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

Inhibition of the autophagic protein ULK1 attenuates axonal degeneration in vitro and in vivo, enhances translation, and modulates splicing.

Rat / Spinal cord injury

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 32341448 ↗2020Reported benefit

Inhibition of the autophagic protein ULK1 attenuates axonal degeneration in vitro and in vivo, enhances translation, and modulates splicing.

RatSpinal cord injuryComplete transectionWistarFemaleIntravitreal injection for SBI-0206965 and AAVs; stereotactic injection into the red nucleus for the spinal cord injury armSBI-0206965 dissolved in DMSO to a 20 mM stock and diluted…SBI-0206965 injected intravitreally 2.5 h before optic nerve crush; AAV.ULK1.DN…

Model: Two in vivo models: optic nerve crush with live imaging of acute axonal degeneration, and spinal cord injury by quadrisection of the contralateral spinal cord producing complete transection of the transduced rubrospinal tract, analysed 1 week after lesion; anaesthesia ketamine 95 mg/kg plus xylazine 7 mg/kg or ketamine 75 mg/kg plus medetomidine 0.5 mg/kg

SBI-0206965 at 50 microM gave a significantly higher Axonal Integrity Ratio than control from 4 h after optic nerve crush, whereas 5 microM did not differ from control. ULK1.DN also attenuated long-term axonal degeneration after spinal cord injury, with reduced LC3 and increased p62 puncta indicati…

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.